Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, <a style="color: #00a9f6; text-decoration: none;" href= "https://www.avalere.com" target="_blank" rel= "noopener">Avalere</a> experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.

Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.

Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, <a href="https://www.avalere.com" rel="noopener noreferrer">Avalere</a> experts discuss how&nbsp;innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.

RSV Prevention, Part I: Pediatric Monoclonal Antibodies

Twenty years ago, Avalere set out to be the essential voice in improving healthcare. Rest your eyes or use your commute time to listen to our experts discuss the hot topics that you need to track.

Share RSV Prevention, Part I: Pediatric Monoclonal Antibodies

Sign up to save your podcasts

RSV Prevention, Part I: Pediatric Monoclonal Antibodies

RSV Prevention, Part I: Pediatric Monoclonal Antibodies